HistoSonics Receives TFDA Approval in Taiwan for Edison Histotripsy System, Accelerating Asia Expansion

HistoSonics receives TFDA approval in Taiwan for Edison Histotripsy System, accelerating Asia expansion

HistoSonics has received regulatory approval from Taiwan’s Food and Drug Administration for its Edison Histotripsy System, a non-invasive cancer treatment device that uses focused ultrasound to destroy tumours without cutting, radiation, or thermal damage. The TFDA authorisation, announced on 18 May, marks a significant step in the company’s expansion into Asia and adds Taiwan to […] This story continues at The Next Web

HistoSonics Receives Landmark TFDA Approval in Taiwan, Accelerating Global Expansion

MINNEAPOLIS--(BUSINESS WIRE)--#Asia--HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced it has received approval from the Taiwan Food and Drug Administration (TFDA) for the Edison® System, representing a significant milestone in the company’s global expansion efforts and continued growth across Asia. Taiwan is widely recognized as one of the more... The post HistoSonics Receives L…

Latest News HistoSonics Receives Landmark TFDA Approval in Taiwan, Accelerating Global Expansion

Business Wire India HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced it has received approval from the Taiwan Food and Drug Administration (TFDA) for the Edison® System, representing a significant milestone in the company’s global expansion efforts and continued growth across Asia.   This press release features multimedia. View the full release here: https://www.businesswire.com…